Harriet Feilotter
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
- Molecular Biology top 5%
- Circular RNAs in diseases
- PI3K/AKT/mTOR signaling in cancer
- Epigenetics and DNA Methylation
Papers in
-
- Cancer Genomics and Diagnostics 20
- MicroRNA in disease regulation 8
- Cancer-related molecular mechanisms research 6
-
- Genetic factors in colorectal cancer 9
- Lymphoma Diagnosis and Treatment 7
- Co-authors
- Victor A. TronXiao ZhangDavid BeachJiamin ChenLois M. MulliganCharis EngAlexander H. BoagPaul G. Young
- Journals
- Journal of Molecular Diagnostics (6 papers)Journal of Clinical Oncology (4 papers)Clinical Cancer Research (3 papers)American Journal Of Pathology (3 papers)PLoS ONE (3 papers)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Harriet Feilotter
67 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 127
- Cancer Research 858
- Molecular Biology 1.8k
- Oncology 669
- Genetics 513
- Biological Psychiatry 33
Countries citing papers authored by Harriet Feilotter
This map shows the geographic impact of Harriet Feilotter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harriet Feilotter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harriet Feilotter more than expected).
Fields of papers citing papers by Harriet Feilotter
This network shows the impact of papers produced by Harriet Feilotter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harriet Feilotter. The network helps show where Harriet Feilotter may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Harriet Feilotter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 11 | |
| 4 | 2024 | 2 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 3 | |
| 7 | 2023 | 0 | |
| 8 | 2022 | 1 | |
| 9 | 2021 | 71 | |
| 10 | 2017 | 79 | |
| 11 | 2016 | 33 | |
| 12 | 2014 | 47 | |
| 13 | 2012 | 47 | |
| 14 | 2012 | 45 | |
| 15 | 2011 | 93 | |
| 16 | 2010 | 211 | |
| 17 | 2008 | 6 | |
| 18 | 2008 | 100 | |
| 19 | 2002 | 6 | |
| 20 | 1992 | 20 |
About Harriet Feilotter
Harriet Feilotter is a scholar working on Cancer Research, Pathology and Forensic Medicine, Oncology, Medical Laboratory Technology and Genetics, having authored 72 papers that have together received 3.0k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (20 papers), Genetic factors in colorectal cancer (9 papers), MicroRNA in disease regulation (8 papers), Colorectal Cancer Treatments and Studies (8 papers), Genomics and Rare Diseases (7 papers), Lymphoma Diagnosis and Treatment (7 papers), BRCA gene mutations in cancer (6 papers) and Cancer-related molecular mechanisms research (6 papers). The work is most often cited by research in Cancer Research (858 citations), Molecular Biology (1.8k citations), Oncology (669 citations), Genetics (513 citations) and Biological Psychiatry (33 citations). Harriet Feilotter has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Victor A. Tron, Xiao Zhang, David Beach, Jiamin Chen, Lois M. Mulligan, Charis Eng, Alexander H. Boag, Paul G. Young, Geneviève C. Paré and Xiaolong Yang. Their work appears in journals such as Journal of Molecular Diagnostics, Journal of Clinical Oncology, Clinical Cancer Research, American Journal Of Pathology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.